Amundi Core MSCI Emerging Markets UCITS ETF EUR Dist (AEMD) Stock

Amundi Core MSCI Emerging Markets UCITS ETF EUR Dist (AEMD) is a Healthcare stock trading at $2.72 (as of 2026-08-20), with a market capitalization of $2.08M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Insufficient source information was provided to describe the company’s business. The only available secondary text relates to Aethlon Medical, Inc., and it does not contain details about “Amundi Core MSCI Emerging Markets UCITS ETF EUR Dist (AEMD)” or any Signals.AI filings.

Valuation — source: SEC EDGAR (first-party)

Price	$2.72
Market Cap	$2.08M
EV / EBITDA	0.4
Price / Book	0.40
Price / Sales	13.31
FCF Yield	-345.2%

Profitability & Growth — source: SEC EDGAR

Revenue (TTM)	$156534.00
Net Margin	-4568.6%
Return on Equity	-133.4%
Current Ratio	5.42
Revenue Growth (YoY)	-47.5%
EPS Growth (YoY)	23.7%
FCF Growth (YoY)	-8.4%

Financial Health — source: SEC EDGAR

Altman Z-Score

-39.03 (distress)

Valuation vs Sector & Industry

Sector P/E (Healthcare)	21.6
Industry P/E (Medical Equipment)	32.9

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures

Top Institutional Holder	BlackRock Fund Advisors ($75000.00)
Institutional Holders Tracked	10

Company

Sector	Healthcare
Industry	Medical Equipment
CEO	James Frakes
Employees	14
Country	US
IPO Date	1999-03-04

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

• Intelligent Bio Solutions Inc. (INBS)
• enVVeno Medical Corporation (NVNO)
• Picard Medical, Inc. (PMI)
• Autonomix Medical, Inc. Common Stock (AMIX)
• Bluejay Diagnostics, Inc. (BJDX)
• Catheter Precision, Inc. (VTAK)
• Sonoma Pharmaceuticals, Inc. (SNOA)
• INVO Fertility, Inc. (IVF)

Data as of 2026-08-20.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.